| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ring finger and FYVE like domain containing E3 ubiquitin protein ligase | 0.41 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.600 | None | 1.000 | 2 | 0 | 1998 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
group | 0.600 | None | 0.964 | 2 | 0 | 1994 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.600 | None | 1.000 | 2 | 0 | 1996 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.530 | None | 1.000 | 1 | 0 | 1998 | 2017 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.360 | None | 1.000 | 1 | 0 | 2005 | 2020 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
group | 0.600 | None | 0.944 | 1 | 0 | 2003 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.230 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.600 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.250 | None | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.600 | None | 0.966 | 2 | 0 | 2001 | 2019 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.600 | None | 0.931 | 2 | 0 | 1993 | 2020 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
group | 0.600 | None | 1.000 | 3 | 0 | 2006 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
group | 0.600 | None | 0.968 | 2 | 0 | 2002 | 2019 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.600 | None | 0.921 | 4 | 0 | 1986 | 2020 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.700 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
group | 0.700 | None | 0.897 | 1 | 0 | 1994 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.540 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
group | 0.600 | None | 0.972 | 1 | 0 | 1998 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.550 | None | 1.000 | 2 | 0 | 1999 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
group | 0.220 | None | 1.000 | 2 | 0 | 2010 | 2019 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2020 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
group | 0.700 | None | 1.000 | 3 | 0 | 1999 | 2020 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
group | 0.600 | None | 0.889 | 1 | 0 | 1998 | 2019 |